FI800205A - Oegonmedicinpreparat avsedda foer lokal behandling av foerhoejt intraokulart tryck vilka innehaoller kolsyraanhydrasinhibitorer och s-(-)-1-(tert-butylamino)-3-/(4-morfolino-1,2,5-tiadiazol-3-yl)oxi/-2-propanol - Google Patents

Oegonmedicinpreparat avsedda foer lokal behandling av foerhoejt intraokulart tryck vilka innehaoller kolsyraanhydrasinhibitorer och s-(-)-1-(tert-butylamino)-3-/(4-morfolino-1,2,5-tiadiazol-3-yl)oxi/-2-propanol

Info

Publication number
FI800205A
FI800205A FI800205A FI800205A FI800205A FI 800205 A FI800205 A FI 800205A FI 800205 A FI800205 A FI 800205A FI 800205 A FI800205 A FI 800205A FI 800205 A FI800205 A FI 800205A
Authority
FI
Finland
Prior art keywords
butylamino
propanol
tert
oegon
morzol
Prior art date
Application number
FI800205A
Other languages
English (en)
Inventor
Robert L Smith
Ralph F Hirschmann
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI800205A publication Critical patent/FI800205A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI800205A 1979-02-02 1980-01-24 Oegonmedicinpreparat avsedda foer lokal behandling av foerhoejt intraokulart tryck vilka innehaoller kolsyraanhydrasinhibitorer och s-(-)-1-(tert-butylamino)-3-/(4-morfolino-1,2,5-tiadiazol-3-yl)oxi/-2-propanol FI800205A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US890379A 1979-02-02 1979-02-02

Publications (1)

Publication Number Publication Date
FI800205A true FI800205A (fi) 1980-08-03

Family

ID=21734364

Family Applications (1)

Application Number Title Priority Date Filing Date
FI800205A FI800205A (fi) 1979-02-02 1980-01-24 Oegonmedicinpreparat avsedda foer lokal behandling av foerhoejt intraokulart tryck vilka innehaoller kolsyraanhydrasinhibitorer och s-(-)-1-(tert-butylamino)-3-/(4-morfolino-1,2,5-tiadiazol-3-yl)oxi/-2-propanol

Country Status (9)

Country Link
EP (1) EP0014642B1 (fi)
JP (1) JPS55122716A (fi)
AT (1) ATE6738T1 (fi)
AU (1) AU536438B2 (fi)
DE (1) DE3067081D1 (fi)
DK (1) DK43280A (fi)
FI (1) FI800205A (fi)
IE (1) IE49507B1 (fi)
NZ (1) NZ192673A (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE50901B1 (en) * 1980-03-04 1986-08-06 Merck & Co Inc Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
GB8822285D0 (en) * 1988-09-22 1988-10-26 Ddsa Pharmaceuticals Ltd Opthalmic preparations
AU2002325220A1 (en) * 2002-05-24 2003-12-12 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol
CN104364241A (zh) * 2012-05-08 2015-02-18 塞利克斯比奥私人有限公司 抑制碳酸酐酶活性的组合物和方法
KR101698163B1 (ko) * 2014-12-19 2017-01-19 동아에스티 주식회사 복령피 추출물을 함유하는 퇴행성 신경질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860371A (en) * 1958-07-03 1961-02-01 Pfizer & Co C Di-sulfonamides and compositions containing them
NL7508856A (nl) * 1974-08-16 1976-02-18 Merck & Co Inc Werkwijze voor het bereiden van preparaten tegen hypertensie.
IL50477A (en) * 1975-09-26 1979-09-30 Merck & Co Inc Ophthalmic compositions containing 1-t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-propanol hydrogen maleate
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls

Also Published As

Publication number Publication date
EP0014642A3 (en) 1981-01-07
IE800207L (en) 1980-08-02
EP0014642A2 (en) 1980-08-20
NZ192673A (en) 1984-07-06
ATE6738T1 (de) 1984-04-15
DK43280A (da) 1980-08-03
JPS55122716A (fi) 1980-09-20
IE49507B1 (en) 1985-10-16
EP0014642B1 (en) 1984-03-21
DE3067081D1 (en) 1984-04-26
AU5487980A (en) 1980-08-07
AU536438B2 (en) 1984-05-10

Similar Documents

Publication Publication Date Title
ATE9059T1 (de) Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension.
LU90839I2 (fr) Kaletra-combinaison de lopinavir et de ritonavir et ses d-riv-s pharmaceutiquement acceptables
ES2150663T3 (es) Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina.
DE3167999D1 (en) Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
SE7707731L (sv) Sett att framstella nya piperidyl-indolderivat och salter derav
FI800205A (fi) Oegonmedicinpreparat avsedda foer lokal behandling av foerhoejt intraokulart tryck vilka innehaoller kolsyraanhydrasinhibitorer och s-(-)-1-(tert-butylamino)-3-/(4-morfolino-1,2,5-tiadiazol-3-yl)oxi/-2-propanol
DE3888778D1 (de) Polyamin-Derivate als antineoplastische Wirkstoffe.
UY24425A1 (es) Derivados de tiol con actividad inhibidora de metalopeptidasa.
FR2402666A1 (fr) 5-iminodaunomycine et medicament la contenant
DE3684461D1 (de) 9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel.
ATE74138T1 (de) Heptanoyl-glu-asp-ala-amino-saeureimmunstimulanten.
ES2042580T3 (es) Composiciones anti-inflamatorias.
AU601583B2 (en) Protected cyclopantanols
GB1259415A (fi)
GB1497729A (en) Benzenesulphonyl ureas and process for their manufacture
FI872997A0 (fi) Amidderivat.
DK17984A (da) Aldosereduktasehaemmende 5-(2-alkoxyphenyl)thiazolidindioner
DK409186A (da) Hydroxyalkyl-phenoxypropan-2-olaminforbindelse og opthalmisk praeparat indeholdende en saadan forbindelse
GB1322153A (en) Carbonyldioxymorphinan derivatives
GB1469200A (en) 3-thiomethyl-2-2-dialkylamino-ethyl-indoles
ES8402836A3 (es) Un procedimiento para la preparacion de derivados de 1,1-dioxido de n-(2-piridil)-2-metil-4-hidroxi-2h-1, 2-benzotiazin-3-carboxamida.
IT1194209B (it) Composti fluorurati ad attivita' analgesica e antiinfiammatoria
GB1276942A (en) Derivatives of chloramphenicol and thiamphenicol

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: MERCK & CO INC.